ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Jorge H. Barón, Jorge E. Núñez McLeod, Selva S. Rivera
Nuclear Technology | Volume 134 | Number 2 | May 2001 | Pages 97-109
Technical Paper | Reactor Safety | doi.org/10.13182/NT01-A3189
Articles are hosted by Taylor and Francis Online.
Construction of the CAREM-25 full-size prototype, a very low power nuclear power station [25 MW(electric)], is scheduled to begin in Argentina in 2001. The CAREM-25 is designed based on principles of inherent safety, passive safety functions, and ease of operation. This paper analyzes the safety philosophy from the point of view of risk by performing a level-III probabilistic safety assessment (PSA) of this prototype. The specific PSA steps are discussed, including a specially developed method to obtain representative initiating events, system analysis by fault trees, event development in event trees, plant and containment response analysis, containment event tree development, consequence calculations, and risk representation. The PSA results are presented and discussed in terms of their own values as well as in comparison to other PSA results performed for larger nuclear power plants (NPPs). The advantages of the CAREM-25 from the risk point of view are studied in terms of the effective reduction of both the probability of severe accident sequences and the potential consequences of such sequences (radiological and emergency preparedness impact). The risk point of view also provides a perspective to analyze the impact of several design modifications in order to further reduce the residual risk of the NPP. These design modifications, several of which have already been included in the prototype, are discussed and evaluated.